References
- Woof JM, Kerr MA. The function of immunoglobulin A in immunity. J Pathol 2006; 208:270-82; PMID:16362985; http://dx.doi.org/10.1002/path.1877
- Brandtzaeg P. Function of mucosa-associated lymphoid tissue in antibody formation. Immunol Invest 2010; 39:303-55; PMID:20450282; http://dx.doi.org/10.3109/08820131003680369
- Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol 2004; 2:123-40; PMID:15040260; http://dx.doi.org/10.1038/nrmicro818
- Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL, Sansonetti PJ, Adak GK, Levine MM. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ 1999; 77:651-66; PMID:10516787
- Paton JC, Paton AW. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev 1998; 11:450-79; PMID:9665978
- Miyashita S, Matsuura Y, Miyamoto D, Suzuki Y, Imai Y. Development of recombinant B subunit of Shiga-like toxin 1 as a probe to detect carbohydrate ligands in immunochemical and flowcytometric application. Glycoconj J 1999; 16:697-705; PMID:11003554; http://dx.doi.org/10.1023/A:1007107425891
- Imai Y, Nagai R, Ono Y, Ishikawa T, Nakagami H, Tanikawa T, Kurohane K. Production of secretory immunoglobulin A against Shiga toxin-binding subunits in mice by mucosal immunization. Infect Immun 2004; 72:889-95; PMID:14742533; http://dx.doi.org/10.1128/IAI.72.2.889-895.2004
- Imai Y, Ishikawa T, Tanikawa T, Nakagami H, Maekawa T, Kurohane K. Production of IgA monoclonal antibody against Shiga toxin binding subunits employing nasal-associated lymphoid tissue. J Immunol Methods 2005; 302:125-35; PMID:15992815; http://dx.doi.org/10.1016/j.jim.2005.05.007
- Tanikawa T, Ishikawa T, Maekawa T, Kurohane K, Imai Y. Characterization of monoclonal immunoglobulin A and G against Shiga toxin binding subunits produced by intranasal immunization. Scand J Immunol 2008; 68:414-22; PMID:18782271; http://dx.doi.org/10.1111/j.1365-3083.2008.02153.x
- Tobisawa Y, Maruyama T, Tanikawa T, Nakanishi K, Kurohane K, Imai Y. Establishment of recombinant hybrid-IgGIgA immunoglobulin specific for Shiga toxin. Scand J Immunol 2011; 74:574-84; PMID:21883352; http://dx.doi.org/10.1111/j.1365-3083.2011.02617.x
- Iwata K, Kurohane K, Nakanishi K, Miyake M, Imai Y. Stable expression and characterization of monomeric and dimeric recombinant hybrid-IgGIgA immunoglobulins specific for Shiga toxin. Biol Pharm Bull 2014; 37:1510-5; PMID:24989136; http://dx.doi.org/10.1248/bpb.b14-00323
- Johansen FE, Braathen R, Brandtzaeg P. The J chain is essential for polymeric Ig receptor-mediated epithelial transport of IgA. J Immunol 2001; 167:5185-92; PMID:11673531; http://dx.doi.org/10.4049/jimmunol.167.9.5185
- Mangeney M, Lingwood CA, Taga S, Caillou B, Tursz T, Wiels J. Apoptosis induced in Burkitt's lymphoma cells via Gb3/DC77, a glycolipid antigen. Cancer Res 1993; 53:5314-9; PMID:8221667
- Inward CD, Williams J, Chant I, Crocker J, Milford D V, Rose PE, Taylor CM. Verocytotoxin-1 induces apoptosis in Vero cells. J Infect 1995; 30:213-8; PMID:7673744; http://dx.doi.org/10.1016/S0163-4453(95)90693-2
- Nakanishi K, Narimatsu S, Ichikawa S, Tobisawa Y, Kurohane K, Niwa Y, Kobayashi H, Imai Y. Production of hybrid-IgG/IgA plantibodies with neutralizing activity against Shiga toxin 1. PLoS One 2013; 8:e80712; PMID:24312238; http://dx.doi.org/10.1371/journal.pone.0080712